Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Rosuvastatin and Ezetimibe Combination in Primary Hypercholesterolemia
NCT03288038Phase 3Completed
- Sponsor
- Shinpoong Pharma
- Start
- Oct 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ezetimibe + rosuvastatin in hypercholesterolemia, sponsored by Shinpoong Pharma. Started Oct 2014; status: completed.
02
Drugs
ezetimibe + rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT03288038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03288038.